Dovemarin 250 mg (Dovesil Calcium Hydrate)

Adult dose

Adults: Administer the following doses of calcium dobesilate hydrate orally. 1. Vascular lesions and retinopathy: 500~1000mg daily 2. Venous disorders: Administer 750mg daily for 1~3 weeks, followed by 500mg daily. Administer after meals with plenty of fluids. Adjust the dose appropriately according to age and symptoms.

This medication should not be used by individuals allergic to this medicine or its components. This medication contains lactose, so individuals with genetic disorders such as galactose intolerance, lactose deficiency, or glucose-galactose absorption disorders should also not use this medication. Patients with poor kidney function should exercise caution when using this medication, especially those with severe kidney disease requiring dialysis may need to reduce the dosage of the drug. Patients with impaired liver function should also use this medication cautiously, and if liver values increase, the therapeutic effects and risks should be reevaluated. This medication contains sodium bisulfite, which may cause allergic reactions or asthma attacks, so caution is advised for patients with asthma or hypersensitivity to sulfites. During the use of this medication, symptoms such as headache, abdominal pain, nausea, diarrhea, vomiting, arthralgia, and myalgia may occur, and liver values may also rise. Rarely, severe side effects such as a decrease in blood cell count may occur, so if high fever or symptoms of infection are present, consult a doctor immediately. If hypersensitivity reactions or skin rashes, facial swelling occur, discontinue the medication and inform medical personnel. Effects on driving or operating machinery are unknown, but caution is needed depending on symptoms. It is advisable to avoid this medication during pregnancy, and it is not recommended during breastfeeding since small amounts may be secreted in breast milk. Safety in children has not been adequately confirmed, so it should be administered cautiously to children. This medication may affect blood test results, so it is important to inform medical personnel before testing. No specific symptoms have been reported for overdose, but if anomalies occur, immediate emergency treatment should be received.

• Agranulocytosis
• Neutropenia
• Leukopenia
• Skin rash
• Allergic dermatitis
• Itching
• Urticaria
• Facial edema
• Anaphylactic reaction
• Headache

This medication should be stored in a tightly closed container to avoid exposure to air and moisture. It is important to maintain the storage temperature between 1 degree and 30 degrees Celsius. Proper storage ensures the medication retains its efficacy for a longer time.

Appearance

White round tablet

Package unit

30 tablets/bottle, 90 tablets/bottle